Loading stock data…
NNNN
$28.90+0.40 (+1.40%)
Market ClosedLast close May 1
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Anbio Biotechnology in the Healthcare sector is trading at $28.90. The stock is currently 48% below its 52-week high of $55.65, remaining 8.9% below its 200-day moving average. Technical signals show neutral RSI of 52 and bearish MACD signal, explaining why NNNN maintains its current current market pressure. The Whystock Score of 80/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$28.90
Potential Downside
87.8%
Whystock Fair Value$3.54
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.20B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
181.80
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
21.24%
Volume
Today's trading volume
6,846
Recent News
3 Undiscovered Gems In The US Market To Watch
In the last week, the United States market has remained flat, yet it has experienced a significant 29% increase over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying stocks that are poised for growth and have not yet captured widespread attention can be key to uncovering potential opportunities.
Unveiling 3 Undiscovered Gems in the US Market
The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.
US Undiscovered Gems To Explore In April 2026
In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by an impressive 30%, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks that have strong fundamentals and growth potential can be a promising strategy for investors looking to capitalize on emerging opportunities.
Discovering US Undiscovered Gems This April 2026
In the last week, the United States market has remained flat, yet it boasts an impressive 30% increase over the past year with earnings expected to grow by 16% annually. In such a dynamic environment, identifying stocks that have not yet caught widespread attention but show potential for growth can be key to finding valuable opportunities.
Undiscovered Gems US Market April 2026
The United States market has experienced a flat performance over the last week, yet it has seen an impressive 30% rise over the past year with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that are poised for growth and remain under the radar can offer unique opportunities for investors seeking to capitalize on these favorable conditions.